Biotricity, Inc.
BTCY
$0.25
$0.00-1.40%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 41.66% | 55.76% | 81.81% | 53.72% | 56.23% |
| Total Depreciation and Amortization | 13.57% | 13.56% | 0.00% | 11.87% | 6,926.67% |
| Total Amortization of Deferred Charges | -36.28% | -40.54% | -86.58% | -72.49% | -31.13% |
| Total Other Non-Cash Items | 163.06% | -34.78% | -85.18% | 6,506.09% | -88.64% |
| Change in Net Operating Assets | -176.98% | 11.09% | -93.46% | -127.57% | 51.38% |
| Cash from Operations | -740.30% | 204.66% | 75.01% | 65.62% | 93.25% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 12.77% | -52.23% | -- | -42.43% | 255.53% |
| Total Debt Repaid | 72.73% | -5.73% | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.69% | -1.67% | 50.83% | -- | 1.67% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 69.72% | -207.77% | -49.82% | -90.77% | 118.51% |
| Foreign Exchange rate Adjustments | 78.56% | 720.00% | 38.95% | 16.60% | -4,725.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -115.49% | -214.21% | 103.81% | -120.61% | 130.17% |